Citations

Citations to this article as recorded by  

• N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets
  Zewen Li, Yongfeng Lao, Rui Yan, Fuhan Li, Xin Guan, Zhilong Dong
  Gene.2025; 936: 149125.     CrossRef
• Proteomics exploration of metformin hydrochloride for diabetic kidney disease treatment via the butanoate metabolism pathway
  Jinxuan Chai, Yan Wang, Sifan Guo, Zhibo Wang, Hongwei Chen, Xian Wang, Dandan Xie, Ying Cai, Shiwei Wang, Zhencai Hu, Aihua Zhang, Shi Qiu
  Journal of Pharmaceutical and Biomedical Analysis.2025; 254: 116584.     CrossRef
• Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study
  Xiao-rong Wang, Zeng Wu, Tong-tong He, Xiao-han Chen, Xiao-fei Jin, Chun-yue Zuo, Shao-ze Yang, Yu Gao, Xiao-hong Zhou, Wei-juan Gao
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Implementing novel complete blood count-derived inflammatory indices in the diabetic kidney diseases diagnostic models
  Ali Hassanzadeh, Mehdi Allahdadi, Sepehr Nayebirad, Nazli Namazi, Ensieh Nasli-Esfahani
  Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
• NR4A1 silencing alleviates high-glucose-stimulated HK-2 cells pyroptosis and fibrosis via hindering NLRP3 activation and PI3K/AKT pathway
  Jin-Meng Li, Zi-Hua Song, Yuan Li, Han-Wen Chen, Han Li, Lu Yuan, Jing Li, Wen-Yue Lv, Lei Liu, Na Wang
  World Journal of Diabetes.2025;[Epub]     CrossRef
• Association between drinking patterns and diabetic kidney disease in United States adults: a cross-sectional study based on data from NHANES 1999–2016
  Xusheng Yang
  Renal Failure.2025;[Epub]     CrossRef
• Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
  Jean Paule Joumaa, Angela Raffoul, Charbel Sarkis, Elizabeth Chatrieh, Sally Zaidan, Philippe Attieh, Frederic Harb, Sami Azar, Hilda E. Ghadieh
  Journal of Clinical Medicine.2025; 14(3): 727.     CrossRef
• Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease
  Hao Wang, Xiuli Zhao, Xiao Wang, Yi Gong, Songping Li, Yanting Gu, Bosai He, Jiahong Wang
  Biochemical Pharmacology.2025; 233: 116795.     CrossRef
• Progress in the application of novel inflammatory indicators in chronic kidney disease
  Wenrui Gao, Xiangyu Wang, Yulin Zou, Sheng Wang, Jun Dou, Senlin Qian
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
  Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu
  Frontiers in Physiology.2025;[Epub]     CrossRef
• Role of polyphenols in the management of diabetic complications
  Jeevika Raina, Atika Firdous, Gurvinder Singh, Rajesh Kumar, Charanjit Kaur
  Phytomedicine.2024; 122: 155155.     CrossRef
• Single-Cell RNA Sequencing Reveals RAC1 Involvement in Macrophages Efferocytosis in Diabetic Kidney Disease
  Yi Song, Yifan Liu, Feng Guo, Lin Zhao, Guijun Qin
  Inflammation.2024; 47(2): 753.     CrossRef
• Role of MCP-1 as an inflammatory biomarker in nephropathy
  Yanlong Liu, Ke Xu, Yuhua Xiang, Boyan Ma, Hailong Li, Yuan Li, Yue Shi, Shuju Li, Yan Bai
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease
  Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto
  BMC Nephrology.2024;[Epub]     CrossRef
• Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning
  Yubing Chen, Lijuan Liao, Baoju Wang, Zhan Wu
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy
  Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
  Journal of Microbiology and Biotechnology.2024; 34(3): 547.     CrossRef
• The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States
  Beverley Adams-Huet, Rafael Zubirán, Alan T. Remaley, Ishwarlal Jialal
  Journal of Clinical Lipidology.2024; 18(4): e518.     CrossRef
• Association of the dietary inflammatory index with complicated diabetic kidney disease in people with diabetes mellitus: evidence from NHANES 2009–2018
  Yixin Rui, Xiumeng Zhang, Hongxiao Xie, Hu Qi, Rong Liu, Nan Zeng
  Acta Diabetologica.2024; 61(11): 1375.     CrossRef
• Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
  DengFeng Li, Fang-Chi Hsu, Nicholette D. Palmer, Liang Liu, Young A. Choi, Mariana Murea, John S. Parks, Donald W. Bowden, Barry I. Freedman, Lijun Ma
  Diabetes.2024; 73(7): 1188.     CrossRef
• Serum L C3-II levels in type 2 diabetic patients with impaired renal functions
  Shahab Ahmed Salıh Gezh, Koksal Deveci, Hakan Sivgin, Figen Guzelgul
  Cytokine.2024; 181: 156683.     CrossRef
• Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia
  Camila Silva de Aquino, Estênio Gabriel Miranda, Francisco José Pascoal Ribeiro Júnior, Hérika Juliana de Araújo Lucena, Jéssica Pará Amaral de Oliveira, João Ferreira Lima Neto, Lênio Airam de Pinho, Miguel Valentim Rodrigues, Pedro Henrique Borges Silve
  Revista de Gestão Social e Ambiental.2024; 18(1): e07716.     CrossRef
• Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review
  Zihan Zhu, Xinyi Deng, Wenqing Xie, Hengzhen Li, Yusheng Li, Zhenhan Deng
  Animal Models and Experimental Medicine.2024; 7(5): 653.     CrossRef
• Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
  YongSheng Cao, Shujie Cao, Jiangang Zhao, Jianqin Zhao, Yanan Zhao, Ying Liu
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes
  Yang Ao, Hao Ye, Xiaohui Liu, Yin Li, Haoyin Liu, Shu Ye, Yepeng Hu, Pan Zhuang, Yu Zhang, Chao Zheng, Jingjing Jiao
  Diabetes, Obesity and Metabolism.2024; 26(11): 5283.     CrossRef
• CYSTATIN C—A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes
  Alexandra-Mihaela Visinescu, Emilia Rusu, Andrada Cosoreanu, Gabriela Radulian
  International Journal of Molecular Sciences.2024; 25(15): 8135.     CrossRef
• Role of proadrenomedullin in the progression of diabetic kidney disease in patients with type 2 diabetes mellitus
  A.M. Urbanovych, A.P. Vereshchynska
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 266.     CrossRef
• Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
  Lingyu Du, Canghui Guo, Shengnan Zeng, Ke Yu, Maodong Liu, Ying Li
  Renal Failure.2024;[Epub]     CrossRef
• Single-cell RNA sequencing in diabetic kidney disease: a literature review
  Wei Tan, Jiaoyan Chen, Yunyan Wang, Kui Xiang, Xianqiong Lu, Qiuyu Han, Mingyue Hou, Jurong Yang
  Renal Failure.2024;[Epub]     CrossRef
• Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
  Suye Zhong, Na Wang, Chun Zhang
  International Journal of Molecular Sciences.2024; 25(16): 9035.     CrossRef
• Serum biomarkers for predicting microvascular complications of diabetes mellitus
  Jiajia Wang, Xiaoyi Song, Ziqiao Xia, Shu Feng, Hangfeng Zhang, Chengjie Xu, Hui Zhang
  Expert Review of Molecular Diagnostics.2024; 24(8): 703.     CrossRef
• Association of Serum Tsukushi Levels with Urinary Albumin-Creatinine Ratio in Type 2 Diabetes Patients
  Yanyan Li, Xia Deng, Xunan Wu, Ligang Zhou, Guoyue Yuan
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3295.     CrossRef
• Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease
  Linjing Huang, Tingting Lin, Meizhen Shi, Peiwen Wu
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2024; 327(4): R410.     CrossRef
• Molecular Therapeutics for Diabetic Kidney Disease: An Update
  Man Guo, Fangfang He, Chun Zhang
  International Journal of Molecular Sciences.2024; 25(18): 10051.     CrossRef
• Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
  Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao, Longyan Yang
  Journal of Diabetes Investigation.2024; 15(12): 1763.     CrossRef
• Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury
  Chenxu Zhang, Zhangxin Ji, Na Xu, Jingjing Yuan, Wen Zeng, Yadong Wang, Qing He, Jiaxing Dong, Xinyu Zhang, Dongmei Yang, Wei Jiang, Yibo Yan, Wencui Shang, Jun Chu, Quangen Chu
  Scientific Reports.2024;[Epub]     CrossRef
• Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
  Pin Zhao, Zhenhao Li, Shilong Xue, Jinshan Cui, Yonghao Zhan, Zhaowei Zhu, Xuepei Zhang
  Scientific Reports.2024;[Epub]     CrossRef
• Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy
  Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang
  Integrative Medicine in Nephrology and Andrology.2024;[Epub]     CrossRef
• Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease
  Hoang Thuy Linh, Megumi Oshima, Keisuke Sako, Masahiro Konishi, Daiki Hayashi, Hajime Sanada, Takahiro Yuasa, Akihiko Koshino, Keisuke Horikoshi, Taichiro Minami, Shunsuke Tsuge, Akira Tamai, Shiori Nakagawa, Ryo Nishioka, Takeshi Zoshima, Kiyoaki Ito, Ic
  Nephrology.2024; 29(12): 909.     CrossRef
• Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
  Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim
  Diabetes & Metabolism Journal.2024; 48(6): 1126.     CrossRef
• Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease
  Marita Liebisch, Gunter Wolf
  Glomerular Diseases.2024; 4(1): 211.     CrossRef
• Characteristics and Risk of Incident Diabetic Nephropathy between Early-onset versus Late-onset Type 2 Diabetics of Nigerian Origin
  Collins Amadi, Johnbosco Chidozie Okafor, Ochuko Otokunefor, Ezra Agbo
  European Journal of Medical and Health Sciences.2024; 6(6): 60.     CrossRef
• Research progress of gut microbiome and diabetic nephropathy
  Chenling Chu, Tapas Ranjan Behera, Ying Huang, Wenhui Qiu, Jiayi Chen, Quanquan Shen
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
  Fengzhao Liu, Zhenyu Yang, Jixin Li, Tao Wu, Xiangyu Li, Lijuan Zhao, Wenru Wang, Wenfei Yu, Guangheng Zhang, Yunsheng Xu
  Molecular Medicine.2024;[Epub]     CrossRef
• Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus
  MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
  Bulletin of Russian State Medical University.2024;[Epub]     CrossRef
• A Narrative Review of New Treatment Options for Diabetic Nephropathy
  Aadhira Pillai, Darshna Fulmali
  Cureus.2023;[Epub]     CrossRef
• Bamboo leaf: A review of traditional medicinal property, phytochemistry, pharmacology, and purification technology
  Yaqian Cheng, Siqi Wan, Linna Yao, Ding Lin, Tong Wu, Yongjian Chen, Ailian Zhang, Chenfei Lu
  Journal of Ethnopharmacology.2023; 306: 116166.     CrossRef
• Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics
  Lan Wei, Yuanyuan Han, Chao Tu
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 117.     CrossRef
• Omics and Artificial Intelligence in Kidney Diseases
  Nadja Grobe, Josef Scheiber, Hanjie Zhang, Christian Garbe, Xiaoling Wang
  Advances in Kidney Disease and Health.2023; 30(1): 47.     CrossRef
• Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
  Soumik Das, Ramanathan Gnanasambandan
  Life Sciences.2023; 316: 121414.     CrossRef
• Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
  Francesca Lanzaro, Annalisa Barlabà, Angelica De Nigris, Federica Di Domenico, Valentina Verde, Emanuele Miraglia del Giudice, Anna Di Sessa
  Journal of Clinical Medicine.2023; 12(4): 1447.     CrossRef
• Novel Biomarkers of Diabetic Kidney Disease
  Jorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, José Cabrales, Tomás Rodríguez-Yanez, María Cardona-Blanco, Juan Montejo-Hernández, Dairo Rodelo Barrios, Jhonny Patiño-Patiño, Elber Osorio Rodríguez
  Biomolecules.2023; 13(4): 633.     CrossRef
• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
  Yiwen Li, Yanfei Liu, Shiwei Liu, Mengqi Gao, Wenting Wang, Keji Chen, Luqi Huang, Yue Liu
  Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
• Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
  Lijun Zhao, Yutong Zou, Yucheng Wu, Linli Cai, Yuancheng Zhao, Yiting Wang, Xiang Xiao, Qing Yang, Jia Yang, Honghong Ren, Nanwei Tong, Fang Liu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications
  Alessandra Scamporrino, Stefania Di Mauro, Agnese Filippello, Grazia Di Marco, Antonino Di Pino, Roberto Scicali, Maurizio Di Marco, Emanuele Martorana, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
  International Journal of Molecular Sciences.2023; 24(11): 9412.     CrossRef
• Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
  Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi
  Renal Failure.2023;[Epub]     CrossRef
• Analysis of Serum Pyrodeath Re-lated Proteins and Renal Injury in Patients with Type 2 DKD
  茹洁 马
  Asian Case Reports in Emergency Medicine.2023; 11(02): 53.     CrossRef
• Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis
  Xiangri Kong, Yunyun Zhao, Xingye Wang, Yongjiang Yu, Ying Meng, Guanchi Yan, Miao Yu, Lihong Jiang, Wu Song, Bingmei Wang, Xiuge Wang
  Chemico-Biological Interactions.2023; 382: 110640.     CrossRef
• Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients
  Heng-Mei Zhu, Na Liu, Dong-Xuan Sun, Liang Luo
  Frontiers in Immunology.2023;[Epub]     CrossRef
• The roles of gut microbiota and its metabolites in diabetic nephropathy
  Hui Zhao, Cheng-E Yang, Tian Liu, Ming-Xia Zhang, Yan Niu, Ming Wang, Jun Yu
  Frontiers in Microbiology.2023;[Epub]     CrossRef
• High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study
  Jiahang Li, Lei Shi, Guohong Zhao, Fei Sun, Zhenxing Nie, Zhongli Ge, Bin Gao, Yan Yang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy
  Raghda Hisham Aljorani, Eman Saadi Saleh , Khalaf Gata Hussein Al Mohammadawi
  Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ).2023; 5: 99.     CrossRef
• Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
  Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova, Lyubov Kolesnikova
  International Journal of Molecular Sciences.2023; 24(15): 12378.     CrossRef
• Evaluation of Neutrophil/Lymphocyte Ratio, Low-Density Lipoprotein/Albumin Ratio, and Red Cell Distribution Width/Albumin Ratio in the Estimation of Proteinuria in Uncontrolled Diabetic Patients
  Duygu Tutan, Murat Doğan
  Cureus.2023;[Epub]     CrossRef
• Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway
  Changqing Xu, Yanxu Cheng, Zongmei Liu, Xiaoyan Fu
  Experimental and Therapeutic Medicine.2023;[Epub]     CrossRef
• Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanisms
  Fei Lu, Jinlei Fan, Fangxuan Li, Lijing Liu, Zhiyu Chen, Ziyu Tian, Liping Zuo, Dexin Yu
  Abdominal Radiology.2023; 49(2): 560.     CrossRef
• Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice
  Minxiu Wang, Qianhui Zhang, Shuaijie Lou, Leiming Jin, Gaojun Wu, Wenqi Wu, Qidong Tang, Yi Wang, Xiaohong Long, Ping Huang, Wu Luo, Guang Liang
  Biomedicine & Pharmacotherapy.2023; 168: 115660.     CrossRef
• Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
  Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Francesca Viazzi
  World Journal of Diabetes.2023; 14(10): 1450.     CrossRef
• Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
  Meng Wu, Zhiyin Pei, Guangfeng Long, Hongbing Chen, Zhanjun Jia, Weiwei Xia
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
  Can Yang, Zhen Zhang, Jieting Liu, Peijian Chen, Jialing Li, Haiying Shu, Yanhui Chu, Luxin Li
  Molecular Medicine.2023;[Epub]     CrossRef
• Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease
  Rongrong Zhu, Yan Yuan, Rourou Qi, Jianying Liang, Yan Shi, Hongbo Weng
  Journal of Chromatography B.2023; 1231: 123930.     CrossRef
• Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
  Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3707.     CrossRef
• GLP-1RA Combined with SGLT2 Inhibitors for the Treatment of Diabetic Kidney Disease: A Meta Analysis
  莹 郭
  Advances in Clinical Medicine.2023; 13(11): 18117.     CrossRef
• Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies
  Li Xia Yu, Min Yue Sha, Yue Chen, Fang Tan, Xi Liu, Shasha Li, Qi-Feng Liu
  Therapeutic Advances in Chronic Disease.2023;[Epub]     CrossRef
• Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease
  Le Gong, Rui Wang, Xinyu Wang, Jing Liu, Zhaodi Han, Qian Li, Yi Jin, Hui Liao
  Renal Failure.2023;[Epub]     CrossRef
• Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis
  Huijuan Lu, Jia Sun, Jieqiong Sun
  Medicine.2023; 102(52): e36802.     CrossRef
• Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease
  Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Maurizio Di Marco, Maria Teresa Di Martino, Francesca Scionti, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
  International Journal of Molecular Sciences.2022; 23(15): 8198.     CrossRef
• Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
  Nam Hoon Kim, Nan Hee Kim
  Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
• Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression
  Yasmin M. Ahmed, Raha Orfali, Nada S. Abdelwahab, Hossam M. Hassan, Mostafa E. Rateb, Asmaa M. AboulMagd
  Pharmaceuticals.2022; 15(10): 1175.     CrossRef
• Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
  Manlin He, Lan Feng, Yang Chen, Bin Gao, Yiwei Du, Lu Zhou, Fei Li, Hongbao Liu
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis
  Sicheng Li, Huidi Xie, Yang Shi, Hongfang Liu
  Medicine.2022; 101(42): e31232.     CrossRef
• Stratification of diabetic kidney diseases via data-independent acquisition proteomics–based analysis of human kidney tissue specimens
  Qinghua Huang, Xianming Fei, Zhaoxian Zhong, Jieru Zhou, Jianguang Gong, Yuan Chen, Yiwen Li, Xiaohong Wu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
  Ziyan Xie, Xinhua Xiao
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Diabetic Kidney Disease
  Susanne B. Nicholas, Amy K. Mottl
  Nephrology Self-Assessment Program.2022; 21(5): 394.     CrossRef